Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
KEY TAKEAWAYS PCOS is now officially called PMOS - Polyendocrine Metabolic Ovarian Syndrome - shifting focus from ovarian problems to metabolic dysfunction 70 million women globally are affected during reproductive years, with 70% remaining undiagnosed The condition can occur at any weight and is driven by insulin resistance and other metabolic signals, not ovarian problems Treatment should focus on metabolic health rather than weight loss or ovarian interventions The name change parallels similar shifts in medicine like MASLD replacing non-alcoholic fatty liver disease NOTABLE QUOTE "Most patients with this label that they've had in the past, the PCOS label, feel a sense of hopelessness, and even join support groups and things like that, and thinking that this will be a condition they have forever
Rates of moderate or worse side effects ranged from 14% to 32%, but few people stopped treatment due to adverse events
Frazy takie jak luna skra po odchudzaniu czy jak ujdrni skr po Mounjaro pokazuj, e pacjenci coraz czciej szukaj sposobw na popraw jakoci skry podczas kuracji
the label states its unknown whether the risk applies to humans, and it lists contraindications including personal/family history of medullary thyroid carcinoma (MTC) or MEN2 (FDA label (PDF))
US$ 27.45
US$ 27.92
US$ 29.77
US$ 22.85
US$ 23.58
US$ 27.28
